Search the Newsreel

Walleye Capital LLC Takes $8.76 Million Position in Heartflow, Inc. $HTFL

Walleye Capital LLC has acquired a new position in Heartflow, Inc. (NASDAQ:HTFL) worth $8.76 million, representing a 0.35% stake. This comes as Heartflow reported strong second-quarter results with revenue up 47.7% and raised its 2026 revenue guidance. Despite the positive financial performance and analyst …

Heartflow (NASDAQ:HTFL) Reaches New 1-Year High After Analyst Upgrade

Heartflow (NASDAQ:HTFL) shares reached a new 52-week high after JPMorgan raised its price target from $35 to $45 and maintained an overweight rating. The company reported strong second-quarter revenue of $64.1 million, a 47.7% year-over-year increase, and raised its full-year 2026 revenue guidance. Despite …

HeartFlow (HTFL) Stock Rally Meets Widening Losses And Premium Valuation

Analysts Are Bullish on Heartflow (HTFL) Stock. Here’s Why

Heartflow Inc. (NASDAQ:HTFL) climbed to a fresh all-time high on Friday, as investors took heart from its strong revenues in the second quarter of the year that helped boost its growth outlook for the full-year period. In intra-day trading, the stock climbed to its …

Why Heartflow Stock Soared Today

Key Points Heartflow's AI-powered platform could save countless lives. The company is growing at an impressive clip.10 stocks we like better than HeartFlow › Shares of Heartflow (NASDAQ: HTFL) jumped on Friday after the medical diagnostics specialist boosted its full-year revenue targets. Image source: …

Lionheart Holdings Submits Q2 2026 SEC Form 10-Q Highlighting SPAC Details and Business Combination Deadline

Lionheart Holdings (NASDAQ: CUB), a SPAC, filed its Q2 2026 SEC Form 10-Q on August 14, 2026, detailing its status as a shell company and outlining its capital structure. The company has a deadline of March 20, 2027, to complete an initial business combination, …

HeartBeam enters $25 million at-the-market equity sales agreement with Titan Partners

HeartBeam Inc. has signed an at-the-market (ATM) equity offering sales agreement with Titan Partners Securities LLC to sell up to $25 million of its common stock. This move comes as the company faces significant cash burn, with levered free cash flow of negative $13.97 …

Form 8K Heartbeam Inc For: 14 August By Investing.com

This article reports that Heartbeam Inc. filed a Form 8K on August 14. The filing is available through Investing.com, which also provides current market data, including stock performance for BEAT, showing a -15.26% change. The content primarily serves as a notice of the filing …

Lionheart Holdings (CUB) posts loss as SPAC extends deal deadline

Lionheart Holdings (CUB), a Cayman Islands SPAC, reported a net loss of $2.7 million for the six months ended June 30, 2026, driven by high general and administrative expenses including a $6.5 million non-redemption agreements expense. The company extended its business combination deadline to …

HTFL (HTFL) investor files Form 144 to sell 200,000 common shares

A holder of Heartflow, Inc. (HTFL) common stock has filed a Form 144 to potentially sell up to 200,000 shares through UBS Financial Services Inc., valued at $8,434,000. This planned sale represents a fraction of the 86,398,778 total common shares outstanding. The filing also …

HeartFlow Shares Soar Following Strong Q2 Results and Upgraded Guidance

Heartland Express (HTLD) family trusts disclose stakes up to 28.3% in 13G/A

An updated Schedule 13G/A filing reveals significant family and trust ownership in Heartland Express (HTLD) common stock. Ann S. Gerdin and her revocable trust each report 14.1% beneficial ownership, while Julie J. Durr reports 27.7% and Angela K. Janssen reports 28.3%. These holdings are …

Heartflow, Inc. SEC Filing (Aug 14, 2026)

Heartflow, Inc. (HTFL) filed a Form 144 with the SEC on August 14, 2026, indicating a proposed sale of 150,000 shares of common equity with an aggregate market value of $6,225,000 through J.P. Morgan Securities LLC. The shares were acquired on March 30, 2026, …

HTFL Maintained by Morgan Stanley -- Price Target Raised to $40.

Heartflow, Inc. Stock 12‑Month Price Target Raised to $43.5, Implies 40% Upside

Heartflow, Inc.'s stock 12-month price target has been increased to $43.5 from $36.62, representing a 40% potential upside based on its closing price on August 13. This revised target comes from estimates by 8 analysts, with forecasts ranging from $39 to $45 per share. …

Lionheart Holdings (CUB): Goldman Sachs reports 1.32M-share, 6.1% ownership stake

HTFL Stock Rockets On Heavy Volume As Traders Pile In

Heartflow, Inc. (HTFL) stock surged over 30% due to optimism surrounding its AI-driven cardiovascular imaging breakthrough. The company, despite running deep losses, boasts strong gross margins, a robust cash position, and low debt, making it attractive for momentum traders despite its speculative growth profile. …

First Trust entities (CUB) report sub-4% stakes in Lionheart Holdings

First Trust entities have filed an amended passive investment disclosure (SCHEDULE 13G/A) revealing their minority stakes in Lionheart Holdings. First Trust Merger Arbitrage Fund (VARBX) holds 3.34% of Class A Ordinary Shares, while First Trust Capital Management L.P., First Trust Capital Solutions L.P., and …

HTFL Maintained by Wells Fargo -- Price Target Raised to $39

Heartflow Shares Surge 34% After $18 Million Guidance Hike Lifts Market Value by Almost $1 Billion

Wells Fargo & Company Issues Positive Forecast for Heartflow (NASDAQ:HTFL) Stock Price

Shanghai HeartCare Seeks Shareholder Approval for Sci-Tech Board A-Share Issuance

Shanghai HeartCare Plans A Share Issue and Sci-Tech Board Listing

Lionheart Holdings (CUB) 5.64% stake reported by Harraden and Fortmiller

Harraden Circle Investments, LLC and Frederick V. Fortmiller, Jr. have reported a beneficial ownership of 1,297,683 Class A shares, representing 5.64% of Lionheart Holdings (CUB), through an amended Schedule 13G filing. This amendment reflects an internal reorganization effective June 30, 2026, and updates the …

Heartflow (NASDAQ:HTFL) Shares Gap Up Following Better-Than-Expected Earnings

Heartflow (NASDAQ:HTFL) shares gapped up after reporting better-than-expected earnings, with an adjusted EPS of $(0.07) against estimates of $(0.22) and quarterly revenue of $64.08 million, up 47.7% year over year. The stock opened significantly higher at $39.06 and traded near $41.07, surpassing the analyst …

Heartflow Inc stock hits all-time high at 41.25 USD

Heartflow Inc. stock reached an all-time high of $41.25, reflecting strong investor confidence and recent market momentum, despite InvestingPro's analysis suggesting it may be overvalued. The company reported better-than-expected Q2 2026 results with significant revenue growth, though it remains unprofitable. Stifel raised its price …

LMR group (CUB) discloses 750,000 Lionheart shares plus warrants for 990,000 more

LMR-affiliated investment managers Ben Levine and Stefan Renold, through funds they manage, have reported a 3.5% passive equity stake in Lionheart Holdings (CUB). As of June 30, 2026, these funds collectively held 750,000 Class A ordinary shares. Additionally, the LMR funds also hold warrants …

Heartflow, Inc. Common Stock Q2 2026 Earnings Call Summary

Heartflow, Inc. Common Stock Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. …

Heartflow (HTFL): BCLS Fund III reports 8.45M-share, 9.8% ownership stake

BCLS Fund III Investments, LP, affiliated with Bain Capital Life Sciences, has reported an 8.45 million-share, 9.8% ownership stake in Heartflow, Inc. (HTFL) as of June 30, 2026. This filing, an Amendment No. 2 to a Schedule 13G/A, indicates that the Bain Capital Life …

Shanghai Bio-heart Sets Board Meeting to Review Interim Results and Possible Dividend

HeartBeam Inc (BEAT) (Q2 2026) Earnings Call Highlights: FDA Submission Advances and Commercial ...

HeartBeam Inc. (NASDAQ:BEAT) reported its Q2 2026 earnings, highlighting significant progress in FDA submissions for heart attack detection and initial commercial launches. Despite reporting a net loss of $5 million, the company reduced its operating cash outflow, extended its cash runway into 2027, and …

HeartFlow projects $246M-$250M 2026 revenue as Plaque outlook rises to $29M-$31M

Earnings Call Insights: HeartFlow (HTFL) Q2 2026 MANAGEMENT VIEW * "Q2 is an outstanding quarter for HeartFlow and the momentum that we entered 2026 with is accelerating," said (President, CEO & Director John Farquhar). "In the second quarter, revenue was $64.1 million, up 48% …

HeartBeam (BEAT): Strome group details 6.8% ownership and July–August share sales

Mark E. Strome and affiliated entities have filed an amended Schedule 13D for HeartBeam, Inc. (BEAT), reporting beneficial ownership of 3,764,200 shares, or 6.8% of the company's common stock. This includes a recent purchase of 750,000 shares in an underwritten public offering. The filing …